Management of ruptured liver segment IV hepatocellular carcinoma: is transarterial embolization (TAE) superior to chemoembolization (TACE)?-the jury is still out

被引:4
|
作者
Bakopoulos, Anargyros [1 ]
Koliakos, Nikolaos [1 ]
Tsilimigras, Diamantis, I [1 ]
Schizas, Dimitrios [1 ]
Moris, Demetrios [2 ]
Angelopoulos, Argiris [3 ]
Spanakos, Spyridon [3 ]
Spartalis, Eleftherios [4 ]
Patapis, Pavlos [1 ]
Skandalakis, Panagiotis [3 ]
Troupis, Theodoros [3 ]
机构
[1] Univ Athens, Attikon Univ Hosp, Sch Med, Dept Surg 3, Rimini 1str, Athens 12462, Greece
[2] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[3] Univ Athens, Fac Med, Dept Anat, Athens, Greece
[4] Univ Athens, Sch Med, Lab Expt Surg & Surg Res, Athens, Greece
关键词
Transarterial embolization (TAE); rupture; hepatocellular carcinoma (HCC); OUTCOMES;
D O I
10.21037/atm.2018.06.01
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HCC rupture is a potentially life-threatening complication owing to underlying vascular dysfunction and coagulopathy. There is still a debate in the literature concerning the best approach in patients presenting in the emergency setting with shock due to spontaneous HCC rupture. In the current report, we describe the case of a 66-year-old female patient with ruptured HCC who was treated successfully by emergency transarterial embolization (TAP) with complete response proved by gradual shrinkage of the tumor. This impressive complete response suggests that TAE followed by elective hepatectomy could be an efficient approach for patients with Child-Pugh class A liver function and adequate liver remnant. More studies are needed in order to construct specific guidelines for the treatment of rHCC that will be based on the disease severity and the patient status.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Role of anti-angiogenesis therapy in the management of hepatocellular carcinoma: The jury is still out
    Hong Sun
    Man-Sheng Zhu
    Wen-Rui Wu
    Xiang-De Shi
    Lei-Bo Xu
    World Journal of Hepatology, 2014, (12) : 830 - 835
  • [22] Role of anti-angiogenesis therapy in the management of hepatocellular carcinoma: The jury is still out
    Sun, Hong
    Zhu, Man-Sheng
    Wu, Wen-Rui
    Shi, Xiang-De
    Xu, Lei-Bo
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (12) : 830 - 835
  • [23] Sequential transarterial chemoembolization (TACE) followed by orthotopic liver transplantation for hepatocellular carcinoma beyond the milan criteria - A prospective study.
    Moench, C
    Grebe, A
    Otto, G
    LIVER TRANSPLANTATION, 2004, 10 (06) : C67 - C67
  • [24] A Decision Analysis Model Identifies the Interval of Efficacy for Transarterial Chemoembolization (TACE) in Cirrhotic Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation
    Thomas A. Aloia
    René Adam
    Didier Samuel
    Daniel Azoulay
    Denis Castaing
    Journal of Gastrointestinal Surgery, 2007, 11 : 1328 - 1332
  • [25] Transarterial Chemoembolization (TACE) As a Bridging Therapy Prior to Liver Transplantation (LTX) in Patients with Hepatocellular Carcinoma (HCC): Do Patients Benefit ?
    Meister, Tobias
    Heinzow, Hauke
    Nass, Dominik
    Koehler, Michael
    Ullerich, Hansjoerg
    Domschke, Wolfram W.
    Domagk, Dirk
    GASTROENTEROLOGY, 2009, 136 (05) : A479 - A479
  • [26] A decision analysis model identifies the interval of efficacy for transarterial chemoembolization (TACE) in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation
    Aloia, Thomas A.
    Adam, Rene
    Samuel, Didier
    Azoulay, Daniel
    Castaing, Denis
    JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (10) : 1328 - 1332
  • [27] Role of preoperative transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma (Hong Kong liver cancer stage IIB)
    Nandy, Kunal
    Varty, Gurudutt P.
    Patkar, Shraddha
    Shah, Tanvi
    Gundavda, Kaival
    Gala, Kunal
    Shetty, Nitin
    Kulkarni, Suyash
    Goel, Mahesh
    WORLD JOURNAL OF SURGERY, 2025, 49 (02) : 483 - 493
  • [28] Low drop-out rate from liver transplant waiting list in patients with hepatocellular carcinoma (HCC) treated with intra-arterial chemo/embolization (TACE/TAE)
    Vizzini, GB
    Luca, A
    D'Antoni, A
    Miraglia, R
    Palazzo, U
    Pietrosi, G
    Mandalà, L
    Gruttadauria, S
    Piazza, T
    Gridelli, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 503 - 503
  • [29] Effects of Oral L-Carnitine on Liver Functions After Transarterial Chemoembolization (TACE) in Intermediate Stage Hepatocellular Carcinoma (HCC) Patients
    Hassan, Abeer A.
    Tsuda, Yasuhiro
    Asai, Akira
    Yokohama, Keisuke
    Ohama, Hideko
    Nakamura, Ken
    Sujishi, Tetsuya
    Tsuchimoto, Yusuke
    Fukunishi, Shinya
    Malak, Mohamed M.
    Arafa, Usama A.
    Hassan, Ali T.
    Kassem, Ali
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2015, 148 (04) : S1021 - S1021
  • [30] Sequential transarterial chemoembolization (TACE) followed by orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) beyond the Milan criteria - A prospective study
    Moench, C
    Grebe, A
    Schuchmann, M
    Herber, S
    Pitton, MB
    Lohse, AW
    Galle, PR
    Otto, G
    JOURNAL OF HEPATOLOGY, 2004, 40 : 5 - 5